Stockreport

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer [Yahoo! Finance]

Turnstone Biologics Corp.  (TSBX) 
PDF Complete response achieved in heavily pre-treated late line patient with progression free survival extending beyond one year Favorable tolerability profile and demons [Read more]